Vaccine Development; Regulatory considerations of new vaccine adjuvants and delivery systems are rev...
Vaccine Development; Regulatory considerations of new vaccine adjuvants and delivery systems are reviewed
About this item
Full title
Vaccine Development; Regulatory considerations of new vaccine adjuvants and delivery systems are reviewed
Publisher
Atlanta: NewsRx
Journal title
Science Letter, 2006, p.1369
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
Sesardic noted, "Because no adjuvant is licensed as a medicinal product in its own right, but only as a component of a particular vaccine, pre-clinical and appropriate toxicology studies need to be designed on a case-by-case basis to evaluate the safety profile of the adjuvant and adjuvant/vaccine combination.
Alternative Titles
Full title
Vaccine Development; Regulatory considerations of new vaccine adjuvants and delivery systems are reviewed
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_209141188
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_209141188
Other Identifiers
ISSN
1538-9111
E-ISSN
1538-9162
How to access this item
Log in as a Library member
